Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (35928)	11/13/2009 3:36:29 PM
From: Spekulatius	of 78667

GENZ, a blast from the past. I owned this one several times in the 90's and around 200-2001. They do have a franchise with their Cerezyme drugs. This manufacturing problem is not the first, they had a production lot contaminated with a virus a while ago as far as I remember and had to shut the whole facility down to get the mess cleaned up. Apparently the cleaning up part did not went too well <ng>. I think they also put a new guy in charge of manufacturing but he may not have had time to turn things around. While their drugs are unique in that they help a small group of people with hereditary diseases they are also incredible expensive (100k+/year and treatment) and charging several times in the US what they charge in other countries for the same drug, that they would be an easy (and rightly so, imo) target of a health care reform.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next